Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.3230
+0.0332 (11.46%)
At close: Apr 21, 2025, 4:00 PM
0.3230
0.00 (0.00%)
Pre-market: Apr 22, 2025, 4:13 AM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $10.72 million as of April 21, 2025. Its market cap has decreased by -92.46% in one year.

Market Cap
10.72M
Enterprise Value
-34.19M
1-Year Change
-92.46%
Ranking
Category
Stock Price
$0.32

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $10.72M, a decrease of -81.06%. That is a compound annual growth rate of -15.98%.

History

DateMarket Cap% Change
Apr 17, 20259.60M-38.85%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 754.22B
UnitedHealth Group 388.75B
Johnson & Johnson 379.48B
AbbVie 306.03B
Novo Nordisk 284.50B
Abbott Laboratories 227.23B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings